COMparison Between All immunoTherapies for Multiple Sclerosis.

NCT03193866 · clinicaltrials.gov ↗

COMPLETED

Status

3526

Enrollment

OTHER

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: Rituximab

Sponsor

Karolinska Institutet

Collaborators

[object Object]
[object Object]